Unknown OBSERVATIONAL NCT01400126

Ultrapure Water System for Hemodialysis Therapy

The Effect of Ultrapure Water System on Hemodialysis Therapy- a Single Center Trial

Sponsor: Tel Aviv Medical Center

Conditions Hemodialysis. System as Compared to Conventional Water System. The Change of Biomarkers CRP, CBC With the Use of Ultra Pure Water System for The Rate of Adverse Events Such as Hypotension During Hemodialysis Therapy With Ultra Pure Water

Updated 6 times since 2017 Last updated: Jul 21, 2011 Started: Aug 31, 2011 Primary completion: Aug 31, 2012 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01400126, this observational or N/A phase trial focuses on Hemodialysis. and System as Compared to Conventional Water System. and remains ongoing. Sponsored by Tel Aviv Medical Center, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tel Aviv Medical Center

Data source: Tel Aviv Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.